• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Arthritis Center

Show Search
Hide Search
  • Disease Information
    • Rheumatoid Arthritis
    • Psoriatic Arthritis
    • Ankylosing Spondylitis
    • Osteoarthritis
    • Gout
    • Osteoporosis
  • Patient Corner
    • Drug Information Sheets
    • Managing Your Arthritis
    • RheumTV – Patient Education Video Library
  • Our Research
    • Patient-Centered Outcomes Research
    • Current Research Studies
    • The Camille Julia Morgan Arthritis Research and Education Fund
  • About Us
    • Appointment Information
    • Contact Us
    • Our Faculty
    • Our Staff
    • Rheumatology Specialty Centers
  • Donate
Home / Ask the Expert / Acute Onset of RA

Acute Onset of RA

February 4, 2013 By Arthritis Center

Question

My mother was recently stricken with the near crippling onset of RA that came on over a 2 week period. In November her rheumatoid factor antibody was 44; she was referred to specialist for treatment. My question has to do with understanding the RA test. She had it rechecked this week and it is now over 2000, is this normal, is this any indication of severity of disease or indication of efficacy ot this treatment? Do the test values help in monitoring therapy?

Answer

There are 2 autoantibody tests that can be helpful in diagnosing rheumatoid arthritis. Rheumatoid factor (RF) is the older of the two tests. Unfortunately, this test is not specific for rheumatoid arthritis and can be seen in other medical conditions such as chronic infections (endocarditis, hepatitis C) and paraproteinemias. Anti-CCP antibodies are much more specific for rheumatoid arthritis. That is these antibodies are not generally found in other conditions. We use the measurement of antibodies to aid in the diagnosis of rheumatoid arthritis and to help with determining prognosis. Individuals who have rheumatoid arthritis and these autoantibodies are more likely to have erosive disease. However, we do not use the antibody titers to determine disease activity over time. Disease activity is determined by a combination of number of tender joints, swollen joints, lab studies, and patient and physician global assessment.

Arthritis Center

Founded in 1998, the Arthritis Center at Johns Hopkins is dedicated to providing quality education to patients and healthcare providers alike.

Primary Sidebar

Ask The Expert Topics

  • Alternative Therapies
  • Ankylosing Spondylitis
  • Associated With Other Illnesses
  • Bursitis and Tendinitis
  • Corticosteroids
  • Diet and Exercise
  • Disease Modifying Antirheumatic Drugs (DMARDs)
  • Enteropathic Arthritis
  • Fibromyalgia
  • General Arthritis
  • Gout, Pseudogout, Other
  • Infectious Arthritis
  • Myositis
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Osteoarthritis
  • Osteonecrosis
  • Osteoporosis
  • Polymyalgia Rheumatica
  • Psoriatic Arthritis
  • Reactive Arthritis
  • Regional Pain: Back and Neck
  • Rehabilitation
  • Rheumatoid Arthritis
  • Surgical Therapy
  • Systemic Lupus Erythematosus (SLE)
  • Systemic Sclerosis
  • Vasculitis
RheumTV Logo

Rheum.TV is an informational platform created to educate patients living with a rheumatic disease. With over 100 disease education videos produced by the team at Johns Hopkins Rheumatology.

Visit Rheum.TV

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Myositis Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

Connect With Us

  • Facebook
  • Twitter
  • YouTube

Johns Hopkins Medicine

© 2023 Johns Hopkins Arthritis Center
Patient Privacy